<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00396994</url>
  </required_header>
  <id_info>
    <org_study_id>AG0071</org_study_id>
    <secondary_id>R01AG025489</secondary_id>
    <nct_id>NCT00396994</nct_id>
  </id_info>
  <brief_title>&quot;VIBES&quot;--Low Magnitude Mechanical Stimulation to Improve Bone Mineral Density</brief_title>
  <official_title>Low Magnitude Mechanical Stimulation (LMMS) to Improve Bone Mineral Density (BMD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hebrew Rehabilitation Center, Boston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Hebrew Rehabilitation Center, Boston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if daily low magnitude, high frequency whole body
      vibration can improve bone density in seniors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The treatment options for osteoporosis, a major health complication in the aged population,
      are limited to pharmacologic interventions, the majority of which are antiresorptive.
      Preliminary data demonstrate that high frequency, low magnitude mechanical stimulation (LMMS)
      can preserve bone mineral density (BMD) by preventing bone resorption due to disuse and
      aging, and can stimulate new bone formation.

      To confirm and extend these observations, this study is a three-year, double-blind,
      randomized, placebo-controlled clinical trial of LMMS in 200 elderly women and men (60 years
      of age and older). A clinical center located in Boston, MA has recruited participants from
      multiple independent living facilities in close geographic proximity. Participants meeting
      the inclusion/exclusion criteria have been randomized to either brief daily exposure to LMMS
      on a vibrating platform or a placebo platform over a three year period. All participants
      receive 1000 mg of elemental calcium and 800 IU of vitamin D per day.

      This study will provide new and important information about the role of low magnitude high
      frequency mechanical stimulation on the skeleton.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in volumetric trabecular BMD of the spine and hip by quantitative computed tomography (CT scan)</measure>
    <time_frame>2 - 3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in biochemical markers of bone formation (Procollagen type 1 N-terminal peptide and Bone Specific Alkaline Phosphatase) and resorption (C-terminal Telopeptide of type I collagen)</measure>
    <time_frame>2 - 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in postural stability</measure>
    <time_frame>2 - 3 years</time_frame>
    <description>Postural stability measured as quiet stance with eyes open for 4 minutes on a Kistler force platform</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in isometric leg extension strength</measure>
    <time_frame>2 - 3 years</time_frame>
    <description>Isometric knee extension strength of the right leg measured with a handheld dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hip muscle area and density</measure>
    <time_frame>2 - 3 years</time_frame>
    <description>Muscle area and density surrounding the hips measured by quantitative computed tomography</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">174</enrollment>
  <condition>Osteopenia</condition>
  <arm_group>
    <arm_group_label>Low magnitude mechanical stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 minutes per day of low magnitude mechanical stimulation using a vibrating platform set at 0.3 g and 30 Hz</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 minutes per day standing on sham low mechanical stimulation platform</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low magnitude mechanical stimulation</intervention_name>
    <description>10 minutes per day of low magnitude mechanical stimulation using a vibrating platform set at 0.3 g and 30 Hz</description>
    <arm_group_label>Low magnitude mechanical stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham low magnitude mechanical stimulation</intervention_name>
    <description>10 minutes per day of low magnitude mechanical stimulation using a sham vibrating platform</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women 60 years and over of all ethnic groups

          -  Weight less than 250 pounds

          -  Absence of terminal cancer or other illness necessitating hospice level services

          -  Capable of following the protocol and of understanding and providing informed consent

          -  Scoring less than 12 on the Short Blessed Test

        Exclusion Criteria:

          -  Immobilization of the axial or lower appendicular skeleton within the last year

          -  Nonambulatory (ambulation with an assistive device will be permitted)

          -  Malignancy other than cured thyroid cancer or skin cancer

          -  Hip replacement or internal fixation, total knee replacement, or lower limb fracture
             within the past year, or bilateral hip replacement

          -  Medications: glucocorticoids, suppressive doses of thyroid hormone as determined by
             screening TSH, anticonvulsant drugs (phenytoin, phenobarbital, carbamazepine),
             estrogen/testosterone replacement, selective estrogen receptor modulators (SERMs),
             PTH, or bisphosphonates more than 1 month in past year, calcitonin therapy within the
             preceding month, fluoride therapy at any time

          -  Paget's disease of bone, rheumatoid arthritis or other connective tissue disorders
             requiring systemic treatment with disease modifying drugs, or a history of Cushing's
             syndrome

          -  Fragility fracture within the past five years unless pharmacologic therapy not to be
             prescribed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas P. Kiel, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Aging Research, Hebrew SeniorLife</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marian T. Hannan, DSc, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Aging Research, Hebrew SeniorLife</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hebrew SeniorLife, Institute for Aging Research</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ward K, Alsop C, Caulton J, Rubin C, Adams J, Mughal Z. Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res. 2004 Mar;19(3):360-9. Epub 2004 Jan 27.</citation>
    <PMID>15040823</PMID>
  </reference>
  <reference>
    <citation>Rubin C, Recker R, Cullen D, Ryaby J, McCabe J, McLeod K. Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety. J Bone Miner Res. 2004 Mar;19(3):343-51. Epub 2003 Dec 22.</citation>
    <PMID>15040821</PMID>
  </reference>
  <reference>
    <citation>Gilsanz V, Wren TA, Sanchez M, Dorey F, Judex S, Rubin C. Low-level, high-frequency mechanical signals enhance musculoskeletal development of young women with low BMD. J Bone Miner Res. 2006 Sep;21(9):1464-74.</citation>
    <PMID>16939405</PMID>
  </reference>
  <reference>
    <citation>Kiel DP, Hannan MT, Barton BA, Bouxsein ML, Lang TF, Brown KM, Shane E, Magaziner J, Zimmerman S, Rubin CT. Insights from the conduct of a device trial in older persons: low magnitude mechanical stimulation for musculoskeletal health. Clin Trials. 2010 Aug;7(4):354-67. doi: 10.1177/1740774510371014. Epub 2010 Jun 22.</citation>
    <PMID>20571129</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2006</study_first_submitted>
  <study_first_submitted_qc>November 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2006</study_first_posted>
  <last_update_submitted>March 18, 2013</last_update_submitted>
  <last_update_submitted_qc>March 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hebrew Rehabilitation Center, Boston</investigator_affiliation>
    <investigator_full_name>Douglas Kiel</investigator_full_name>
    <investigator_title>Director Musculoskeletal Research Center</investigator_title>
  </responsible_party>
  <keyword>biomechanics</keyword>
  <keyword>osteogenesis</keyword>
  <keyword>osteoporosis</keyword>
  <keyword>bone regeneration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

